Furosemide
Average across 19 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| HF Acquisition Co. LLC, DBA HealthFirst | repackager | 11 | SUPPLYING |
| Sagent Pharmaceuticals | generic | 6 | SUPPLYING |
| Fresenius Kabi, USA LLC | generic | 6 | SUPPLYING |
| Hospira, Inc. | brand | 6 | SUPPLYING |
| Gland Pharma Limited | generic | 6 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | generic | 5 | SUPPLYING |
| Cardinal Health 107, LLC | repackager | 4 | SUPPLYING |
| Avenacy, LLC | unknown | 3 | SUPPLYING |
| Eugia US LLC | generic | 3 | SUPPLYING |
| Medical Purchasing Solutions, LLC | repackager | 2 | SUPPLYING |
| Henry Schein, Inc. | relabeler | 1 | SUPPLYING |
| Phlow Corporation | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Furosemide Injection — reported in shortage by Meitheal Pharmaceuticals, Inc.. Therapeutic category: Cardiovascular.
Furosemide Injection — reported in shortage by Gland Pharma Limited. Therapeutic category: Cardiovascular.
Furosemide Injection — reported in shortage by Eugia US LLC. Therapeutic category: Cardiovascular.
Furosemide Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Cardiovascular.
Furosemide Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Cardiovascular.
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico
Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial — Recalling firm: Hospira, Inc. — Nationwide
